• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目标性预防与普遍性预防。一种资源分配模型,用于确定心血管疾病预防的优先顺序。

Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention.

机构信息

Centre for Prevention and Health Services Research, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

出版信息

Cost Eff Resour Alloc. 2011 Oct 6;9(1):14. doi: 10.1186/1478-7547-9-14.

DOI:10.1186/1478-7547-9-14
PMID:21974836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3200148/
Abstract

BACKGROUND

Diabetes mellitus brings an increased risk for cardiovascular complications and patients profit from prevention. This prevention also suits the general population. The question arises what is a better strategy: target the general population or diabetes patients.

METHODS

A mathematical programming model was developed to calculate optimal allocations for the Dutch population of the following interventions: smoking cessation support, diet and exercise to reduce overweight, statins, and medication to reduce blood pressure. Outcomes were total lifetime health care costs and QALYs. Budget sizes were varied and the division of resources between the general population and diabetes patients was assessed.

RESULTS

Full implementation of all interventions resulted in a gain of 560,000 QALY at a cost of €640 per capita, about €12,900 per QALY on average. The large majority of these QALY gains could be obtained at incremental costs below €20,000 per QALY. Low or high budgets (below €9 or above €100 per capita) were predominantly spent in the general population. Moderate budgets were mostly spent in diabetes patients.

CONCLUSIONS

Major health gains can be realized efficiently by offering prevention to both the general and the diabetic population. However, a priori setting a specific distribution of resources is suboptimal. Resource allocation models allow accounting for capacity constraints and program size in addition to efficiency.

摘要

背景

糖尿病会增加心血管并发症的风险,患者可以从中受益于预防措施。这种预防措施也适用于普通人群。问题是,哪种策略更好:针对普通人群还是糖尿病患者?

方法

我们开发了一个数学规划模型,以计算以下干预措施在荷兰人群中的最佳分配:戒烟支持、饮食和运动以减轻超重、他汀类药物以及降低血压的药物。结果是总终身医疗保健成本和 QALY。我们改变了预算规模,并评估了在普通人群和糖尿病患者之间分配资源的情况。

结果

全面实施所有干预措施可获得 56 万个 QALY,人均成本为 640 欧元,平均每 QALY 约为 12900 欧元。这些 QALY 增益的绝大部分可以在增量成本低于 20,000 欧元/QALY 的情况下获得。低或高预算(人均低于 9 欧元或高于 100 欧元)主要用于普通人群。中等预算主要用于糖尿病患者。

结论

通过向普通人群和糖尿病患者提供预防措施,可以高效地实现重大健康收益。但是,预先设定特定的资源分配是次优的。资源分配模型除了考虑效率之外,还可以考虑能力限制和项目规模。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24a/3200148/9d8cb8b9b4a6/1478-7547-9-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24a/3200148/e8e5ddb2571f/1478-7547-9-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24a/3200148/9d8cb8b9b4a6/1478-7547-9-14-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24a/3200148/e8e5ddb2571f/1478-7547-9-14-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b24a/3200148/9d8cb8b9b4a6/1478-7547-9-14-2.jpg

相似文献

1
Targeted versus universal prevention. a resource allocation model to prioritize cardiovascular prevention.目标性预防与普遍性预防。一种资源分配模型,用于确定心血管疾病预防的优先顺序。
Cost Eff Resour Alloc. 2011 Oct 6;9(1):14. doi: 10.1186/1478-7547-9-14.
2
3
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.阿仑膦酸盐、依替膦酸盐、利塞膦酸盐、雷洛昔芬和特立帕肽用于预防和治疗绝经后骨质疏松症的系统评价与经济学评估
Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220.
4
Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.他汀类药物用于荷兰新诊断 2 型糖尿病患者一级预防的成本效益分析。
Value Health. 2014 Mar;17(2):223-30. doi: 10.1016/j.jval.2013.12.010.
5
Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events.阿托伐他汀:对其在心血管事件一级和二级预防中应用的药物经济学综述。
Pharmacoeconomics. 2007;25(12):1031-53. doi: 10.2165/00019053-200725120-00005.
6
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.瑞格列奈:对其在2型糖尿病治疗中应用的药物经济学综述
Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005.
7
Universal Health Coverage and Essential Packages of Care全民健康覆盖与基本医疗服务包
8
9
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
10
Optimal allocation of resources across four interventions for type 2 diabetes.2型糖尿病四种干预措施的资源优化配置
Med Decis Making. 2002 Sep-Oct;22(5 Suppl):S80-91. doi: 10.1177/027298902237704.

引用本文的文献

1
Impact of a Parent Education Program Delivered by Nurses and Health Care Providers in Reducing Infant Physical Abuse Hospitalization Rates in British Columbia, Canada.护士和医疗保健提供者实施的家长教育计划对降低加拿大不列颠哥伦比亚省婴儿身体虐待住院率的影响。
Can J Nurs Res. 2024 Mar;56(1):109-116. doi: 10.1177/08445621231222527. Epub 2023 Dec 19.
2
Health care input constraints and cost effectiveness analysis decision rules.医疗保健投入约束与成本效果分析决策规则。
Soc Sci Med. 2018 Mar;200:59-64. doi: 10.1016/j.socscimed.2018.01.026. Epub 2018 Jan 28.
3
Cost-effectiveness of population-based, community, workplace and individual policies for diabetes prevention in the UK.

本文引用的文献

1
Chronic disease projections in heterogeneous ageing populations: approximating multi-state models of joint distributions by modelling marginal distributions.异质老龄化人群中的慢性病预测:通过对边际分布建模来近似联合分布的多状态模型
Math Med Biol. 2010 Mar;27(1):1-19. doi: 10.1093/imammb/dqp014. Epub 2009 Jun 10.
2
Cost-effectiveness of lifestyle modification in diabetic patients.糖尿病患者生活方式改变的成本效益
Diabetes Care. 2009 Aug;32(8):1453-8. doi: 10.2337/dc09-0363. Epub 2009 May 12.
3
The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
基于人群、社区、工作场所和个人政策预防英国糖尿病的成本效益。
Diabet Med. 2017 Aug;34(8):1136-1144. doi: 10.1111/dme.13349. Epub 2017 Apr 18.
4
Modelling the cost-effectiveness of preventing major depression in general practice patients.模拟全科医疗患者中预防重度抑郁症的成本效益
Psychol Med. 2014 May;44(7):1381-90. doi: 10.1017/S0033291713002067. Epub 2013 Aug 15.
在荷兰初级医疗保健中实施心血管风险管理新指南的成本效益。
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):371-6. doi: 10.1097/HJR.0b013e328329497a.
4
Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands.对所有人进行降脂治疗可大幅减轻荷兰糖尿病患者大血管并发症的负担。
Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):521-5. doi: 10.1097/HJR.0b013e3283041523.
5
The economic analyses of the UK prospective diabetes study.
Diabet Med. 2008 Aug;25 Suppl 2:47-51. doi: 10.1111/j.1464-5491.2008.02502.x.
6
Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.戒烟对疾病发病率、死亡率和生活质量的动态影响:戒烟时间的作用。
Cost Eff Resour Alloc. 2008 Jan 11;6:1. doi: 10.1186/1478-7547-6-1.
7
A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol.关于面对面行为干预在吸烟、体育活动、饮食和饮酒方面成本效益的综述。
Chronic Illn. 2007 Jun;3(2):101-29. doi: 10.1177/1742395307081732.
8
Pharmaco-economic issues for diabetes therapy.
Best Pract Res Clin Endocrinol Metab. 2007 Dec;21(4):657-85. doi: 10.1016/j.beem.2007.08.002.
9
The costs, effects and cost-effectiveness of counteracting overweight on a population level. A scientific base for policy targets for the Dutch national plan for action.在人群层面应对超重问题的成本、效果及成本效益。荷兰国家行动计划政策目标的科学依据。
Prev Med. 2008 Feb;46(2):127-32. doi: 10.1016/j.ypmed.2007.07.029. Epub 2007 Aug 3.
10
Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting.糖尿病及其并发症的计算机建模:胡德山挑战赛第四次会议报告
Diabetes Care. 2007 Jun;30(6):1638-46. doi: 10.2337/dc07-9919.